Deep brain stimulation for autism spectrum disorder

Area of Science:

• Neuroscience
• Psychiatry
• Medical Technology

Background:

• Autism spectrum disorder (ASD) is a developmental disability with social, communicative, and behavioral challenges.
• Many individuals with ASD experience severe comorbidities, including treatment-resistant obsessive-compulsive disorder and self-injurious behavior (SIB).
• Existing pharmacological treatments for these comorbidities in ASD are often challenging and ineffective.

Purpose of the Study:

• To review the current literature on the efficacy of deep brain stimulation (DBS) for individuals with autism spectrum disorder (ASD).
• To assess the therapeutic outcomes of DBS in patients with treatment-resistant symptoms associated with ASD.

Main Methods:

• A literature search was conducted using the PubMed database to identify relevant studies on DBS for ASD.
• Thirteen studies involving a total of 16 patients (4 adolescents, 12 adults) with treatment-resistant symptoms were analyzed.
• DBS target sites included the nucleus accumbens, globus pallidus internus, and basolateral amygdala, among others.

Main Results:

• Patients with ASD undergoing DBS showed clinical improvements, as indicated by psychopathological scale scores.
• Improvements were observed in individuals with treatment-resistant obsessive-compulsive symptoms and self-injurious behaviors.
• Variability in clinical improvements over time suggests a need for ongoing investigation and management.

Conclusions:

• Deep brain stimulation (DBS) represents a potential therapeutic option for select individuals with severe, treatment-resistant symptoms of autism spectrum disorder (ASD).
• Further in-depth research is required to establish the long-term efficacy, safety, and optimal application of DBS in ASD management.
• DBS may offer a novel approach for managing debilitating comorbidities in ASD when conventional treatments fail.